Remove Investing Remove Securities and Exchange Commission (SEC) Remove Whitepaper
article thumbnail

Better Buy: Ripple vs. Shiba Inu

The Motley Fool

This was true even while American crypto exchanges kept their hands off the XRP token due to potential legal trouble from the Securities and Exchange Commission's (SEC) long-running lawsuit. Judge Analisa Torres dismissed two of the SEC's three lawsuit claims on July 13, and most U.S.

article thumbnail

Sarepta Therapeutics (SRPT) Q4 2023 Earnings Call Transcript

The Motley Fool

The press release is available on our website at sarepta.com, and our 10-Q was filed with the Securities and Exchange Commission this afternoon. Should you invest $1,000 in Sarepta Therapeutics right now? billion of cash, cash equivalents, restricted cash, and investments on our balance sheet.